| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |